|
Yes, to national pharmacare – because we already paid for it
Tuesday, June 25th, 2019
We are paying, in effect, three times: through federal research grants, through disease-focused charities, and then at the pharmacy. A national pharmacare program could change this if… the cost of a drug over the life of its patent was calculated to recognize the public support its development received. Manufacturers would submit a funding history with a tentative pricing. A fair rate of return would be permitted for the life of a patent based on that information.
Tags: budget, Health, jurisdiction, mental Health, pharmaceutical
Posted in Health Debates | No Comments »
Recent Comments